000 | 01661 a2200481 4500 | ||
---|---|---|---|
005 | 20250514224438.0 | ||
264 | 0 | _c20050510 | |
008 | 200505s 0 0 eng d | ||
022 | _a0300-8916 | ||
024 | 7 |
_a10.1177/030089160509100109 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aErdem, Ozlem | |
245 | 0 | 0 |
_aThe prognostic value of p53 and c-erbB-2 expression, proliferative activity and angiogenesis in node-negative breast carcinoma. _h[electronic resource] |
260 |
_bTumori _c |
||
300 |
_a46-52 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
650 | 0 | 4 |
_aBreast Neoplasms _xblood supply |
650 | 0 | 4 |
_aCarcinoma, Ductal, Breast _xblood supply |
650 | 0 | 4 | _aCell Proliferation |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aKi-67 Antigen _xanalysis |
650 | 0 | 4 | _aLymphatic Metastasis |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeovascularization, Pathologic |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 |
_aProgesterone _xanalysis |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aReceptor, ErbB-2 _xanalysis |
650 | 0 | 4 |
_aReceptors, Estrogen _xanalysis |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xanalysis |
700 | 1 | _aDursun, Aye | |
700 | 1 | _aCoşkun, Uğur | |
700 | 1 | _aGünel, Nazan | |
773 | 0 |
_tTumori _gvol. 91 _gno. 1 _gp. 46-52 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/030089160509100109 _zAvailable from publisher's website |
999 |
_c15517231 _d15517231 |